Articles with "myc amplified" as a keyword



Photo from wikipedia

BIOL-10. DISTRIBUTION AND VULNERABILITY OF TRANSCRIPTIONAL OUTPUTS ACROSS THE GENOME IN MYC-AMPLIFIED MEDULLOBLASTOMA CELLS

Sign Up to like & get
recommendations!
Published in 2021 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noab090.017

Abstract: Abstract Myc plays a central role in tumorigenesis by orchestrating the expression of genes essential to numerous cellular processes. While it is well established that Myc functions by binding to its target genes to regulate… read more here.

Keywords: amplified medulloblastoma; genome myc; transcriptional outputs; myc amplified ... See more keywords

Abstract 4407: Clinicopathologic characteristics and mutational analysis of MYC amplified head and neck squamous cell carcinoma (HNSCC)

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-4407

Abstract: Amplification of MYC proto-oncogene is commonly found in many types of cancer, and frequently associated with poor clinical outcomes. Analysis of the TCGA-HNSCC dataset indicates that MYC amplification is estimated to be present in ~12%… read more here.

Keywords: myc amplified; amplification; hnscc; cancer ... See more keywords
Photo from wikipedia

Abstract 523: Targeting myc-amplified cancers with a novel prodrug inhibiting aurora A kinase

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-523

Abstract: Upregulation of Aurora kinases has been associated with increased tumor progression, and thus they are appealing targets for the development of anti-cancer therapies. In addition to have a critical role in cell cycle regulation, Aurora… read more here.

Keywords: aurora kinase; myc amplified; kinase; targeting myc ... See more keywords
Photo by chernus_tr from unsplash

The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.14911

Abstract: Medulloblastoma is comprised of at least four molecular subgroups with distinct clinical outcome (WHO classification 2016). SHH-TP53-mutated as well as MYC-amplified Non-WNT/Non-SHH medulloblastoma show the worst prognosis. Here we present evidence that single application of… read more here.

Keywords: pi3k; shh tp53; medulloblastoma; anti neoplastic ... See more keywords

Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways

Sign Up to like & get
recommendations!
Published in 2022 at "Cancers"

DOI: 10.3390/cancers14051311

Abstract: Simple Summary The oncogene MYC alters cellular metabolism. Medulloblastoma is the most common malignant pediatric brain tumor. MYC-amplified medulloblastoma has a poor prognosis, and the metabolism of MYC-amplified medulloblastoma is poorly understood. We performed comprehensive… read more here.

Keywords: myc amplified; comprehensive metabolic; brain; myc ... See more keywords
Photo by cdc from unsplash

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15092525

Abstract: Simple Summary MYC is a well-described oncogene across multiple cancer types. In medulloblastoma (MB), significance is subtype-dependent and associated with a particularly dismal outcome in MYC-amplified group 3 MBs. In our study, we established a… read more here.

Keywords: myc amplified; disease; amplification; myc ... See more keywords
Photo by nci from unsplash

Reciprocal antagonistic regulation of N-myc mRNA by miR-17 and the neuronal-specific RNA-binding protein HuD

Sign Up to like & get
recommendations!
Published in 2017 at "Oncology Reports"

DOI: 10.3892/or.2017.5664

Abstract: Neuroblastoma is a childhood cancer originating from embryonic neural crest cells. Amplification of the proto-oncogene N-myc, seen in ~30% of neuroblastoma tumors, is a marker for poor prognosis. Recently discovered small regulatory RNAs, microRNAs (miRNAs),… read more here.

Keywords: specific rna; neuronal specific; myc mrna; myc amplified ... See more keywords